Sodium glycerophosphate
- Generic Name
- Sodium glycerophosphate
- Brand Names
- Glycophos, Olimel, Periolimel
- Drug Type
- Small Molecule
- Chemical Formula
- C3H7Na2O6P
- CAS Number
- 1334-74-3
- Unique Ingredient Identifier
- G43E72677U
- Background
Sodium glycerophosphate is one of several glycerophosphate salts. It is used clinically to treat or prevent low phosphate levels . Glycerophosphate is hydrolyzed to inorganic phosphate and glycerol in the body . The extent of this reaction is dependent on the activity of serum alkaline phosphatases.
- Indication
Sodium glycerophosphate is indicated for use as a source of phosphate in total parenteral nutrition . It is used in combination with amino acids, dextrose, lipid emulsions, and other electrolytes.
- Associated Therapies
- Total parenteral nutrition therapy
A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E
Phase 1
Recruiting
- Conditions
- Parenteral Nutrition
- Interventions
- Drug: Numeta G16%E
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 16
- Registration Number
- NCT06842134
- Locations
- 🇺🇸
Austin PPD CRU, Austin, Texas, United States
A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP)
Phase 1
Recruiting
- Conditions
- Parenteral Nutrition
- Interventions
- Drug: Sodium Phosphates Injection
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 42
- Registration Number
- NCT06842121
- Locations
- 🇺🇸
Austin PPD CRU, Austin, Texas, United States
The Efficacy and Safety of Diluted Oral Phosphate Enema Versus Intravenous Sodium Glycerophosphate in the Treatment of Hypophosphatemia in ICU Patients
Phase 2
Recruiting
- Conditions
- Acute Hypophosphatemia
- Interventions
- Drug: Enema Phosphates Sodium
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 40
- Registration Number
- NCT06651892
- Locations
- 🇪🇬
Al haram Hospital, Giza, Egypt
Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICU
Phase 4
- Conditions
- Hypophosphatemia
- Interventions
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 100
- Registration Number
- NCT04519762
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath